Lori Lyons-Williams

Lori Lyons-Williams has a long history of work experience in the biotech industry. In 2004, they began their career at Allergan, Inc. as a Senior Region Manager. Lori then moved up the ranks at Allergan, holding various roles such as Vice President, Sales and Marketing, Urology, Senior Director of Marketing, Urology, Director, Botox OAB Franchise, Product Director, Dermatology Brands, and Senior Product Manager, Botox. In 2015, they took on the role of Director at Girls, Inc. In 2016, they became Chief Commercial Officer at Dermira, Inc. In 2019, Lori joined the Board of Five Prime Therapeutics, Inc. (NASDAQ: FPRX) as an Independent Director. In 2021, they were appointed President and Chief Operating Officer at Neumora, as well as Independent Director at RAPT Therapeutics. Lori is currently the Chief Executive Officer of a stealth biotech company.

Lori Lyons-Williams completed their MBA in Marketing and International Business from the University of Minnesota - Carlson School of Management in 2007. Prior to that, they earned their BA in Pre-Med from Virginia Tech between 1995 and 1998.